Search results
Futility in TAVI
Author(s):
Kush P Patel
,
Thomas Treibel
,
Paul Scully
,
et al
Added:
2 years ago
Article
Author(s):
Alfonso Ielasi
,
Alaide Chieffo
Added:
3 years ago
A critical stenosis in left main coronary artery (LMCA) is observed in 3–5% of all patients who undergo coronary angiography and in 10–30% of patients who undergo coronary artery bypass grafting (CABG).1 Significant LMCA disease is a high-risk condition because of the extent of jeopardised myocardium.
Current practice guidelines recommend CABG as the standard therapy for patients with…
View more
Author(s):
Simon Kennon
,
Zhan Lim
Added:
3 years ago
The main advantages of transcatheter aortic valve implantation (TAVI) over conventional aortic valve replacement (cAVR) surgery are the avoidance of sternotomy, heart lung bypass and prolonged procedure times. These advantages facilitate early mobilisation and discharge – important both clinically and in terms of resource utilisation. Balanced against this, TAVI is less predictable than cAVR –…
View more
Transcatheter Edge-to-edge Repair
Author(s):
Francesco Maisano
,
Anita W Asgar
,
,
et al
Start date:
Nov 08, 2022
Broadcast
Kendra J Grubb
Research Area(s) / Expertise:
Job title: Surgical Director
Author
Transcatheter Edge-To-Edge Repair
Video Series
Author(s):
Grégory Ducrocq
,
Dominique Himbert
,
Eric Brochet
,
et al
Added:
3 years ago
Aortic stenosis (AS) is currently the most frequent native valve disease in Europe and is most often seen in elderly patients with co-morbidities.1 Valve replacement is the definitive therapy for patients with severe AS who have symptoms or objective consequences such as left ventricular (LV) dysfunction.2,3 However, the risk of surgery may be higher in elderly patients with significant co…
View more
Author(s):
Chad A Kliger
Added:
3 years ago
Mitral regurgitation (MR) is a complex disorder requiring the understanding of mitral anatomy and pathophysiology. With the increasing patient population of mitral regurgitation, both functional and degenerative types, and our desire for less invasive treatment approaches, transcatheter mitral valve therapies (TMVT) have emerged. After more than a decade of advancements, development in TMVT still…
View more